# Budget & Financial Planning - FY 2124

## Annual Budget Overview

**Fiscal Year**: January 1 - December 31, 2124
**Total Revenue Budget**: $47.3 billion
**Total Operating Budget**: $41.1 billion
**Target Net Income**: $6.2 billion (13.1% margin)

## Revenue Budget by Segment

| Segment | FY 2123 Actual | FY 2124 Budget | Growth |
|---------|----------------|----------------|--------|
| Positronic Companion Series (PCS) | $18.2B | $19.8B | 8.8% |
| Industrial Automation Platform (IAP) | $14.7B | $16.4B | 11.6% |
| Neural Interface Modules (NIM) | $5.8B | $7.2B | 24.1% |
| Synthetic Consciousness Engine (SCE) | $3.1B | $3.9B | 25.8% |
| **Total Revenue** | **$41.8B** | **$47.3B** | **13.2%** |

## Operating Budget by Department

| Department | Budget | % of Total | YoY Change |
|------------|--------|------------|------------|
| Research & Development | $8.51B | 18.0% | +14.2% |
| Operations | $21.34B | 45.1% | +11.8% |
| Sales & Marketing | $6.15B | 13.0% | +9.4% |
| General & Administrative | $3.08B | 6.5% | +5.2% |
| Human Resources | $0.89B | 1.9% | +8.5% |
| Finance | $0.18B | 0.4% | +3.2% |
| Legal | $0.09B | 0.2% | +4.8% |
| IT Infrastructure | $0.86B | 1.8% | +12.4% |
| **Total Operating** | **$41.10B** | **86.9%** | **+11.3%** |

## R&D Budget Allocation

### By Research Area (Total: $8.51B)

| Area | Allocation | Lead |
|------|------------|------|
| Consciousness Research | $2.40B | Dr. Yuki Tanaka |
| Robotics & Automation | $1.89B | Dr. Ahmed Hassan |
| Neural Interfaces | $1.42B | Dr. Wei Zhang |
| Safety & Alignment | $0.95B | Dr. Marcus Thompson |
| Platform Engineering | $0.89B | Jennifer Morrison |
| Basic Research | $0.67B | Various |
| External Partnerships | $0.29B | University Relations |

### By Project

| Project | Allocation | Status |
|---------|------------|--------|
| Project Prometheus | $740M | Phase 3 (Active) |
| Project Atlas | $341M | Phase 2 (Active) |
| Project Hermes | $245M | Phase 2 (Active) |
| PCS v4 Development | $189M | Phase 1 |
| IAP 3.0 Development | $312M | Phase 2 |
| NIM 2.0 Development | $178M | Phase 1 |
| SCE v4 Development | $267M | Planning |
| Other Projects | $1.23B | Various |

## Capital Expenditure Budget

**Total CapEx Budget**: $2.8 billion

| Category | Allocation | Major Items |
|----------|------------|-------------|
| Manufacturing Equipment | $1.24B | Austin Line 4, Shanghai expansion |
| Facilities | $0.67B | Singapore campus Phase 2 |
| IT Infrastructure | $0.45B | Quantum computing cluster |
| R&D Equipment | $0.34B | Advanced testing systems |
| Other | $0.10B | Various |

## Headcount Budget

| Department | Current | Budgeted | Net Change |
|------------|---------|----------|------------|
| R&D | 2,847 | 3,124 | +277 |
| Operations | 4,128 | 4,312 | +184 |
| Sales & Marketing | 2,847 | 3,012 | +165 |
| G&A | 1,247 | 1,298 | +51 |
| HR | 423 | 445 | +22 |
| Finance | 847 | 867 | +20 |
| Legal | 187 | 198 | +11 |
| IT | 321 | 358 | +37 |
| **Total** | **12,847** | **13,614** | **+767** |

## Financial Targets

### Profitability
- **Gross Margin**: 52.4% (vs 51.8% FY 2023)
- **Operating Margin**: 16.2% (vs 15.4% FY 2023)
- **Net Margin**: 13.1% (vs 12.6% FY 2023)

### Efficiency
- **Revenue per Employee**: $3.47M (vs $3.25M FY 2023)
- **R&D Efficiency**: 5.6x return on R&D spend
- **SG&A as % Revenue**: 19.5% (vs 20.1% FY 2023)

### Cash Flow
- **Operating Cash Flow**: $7.2B
- **Free Cash Flow**: $5.8B
- **Cash Conversion**: 94%

## Budget Approval History

| Date | Version | Approved By | Notes |
|------|---------|-------------|-------|
| Oct 15, 2123 | Draft 1 | CFO | Initial submission |
| Nov 3, 2123 | Draft 2 | CEO | Revised R&D allocation |
| Nov 18, 2123 | Final | Board | Approved unanimously |

## Quarterly Targets

| Quarter | Revenue | Operating Income | Notes |
|---------|---------|------------------|-------|
| Q1 2124 | $10.8B | $1.68B | Seasonally lower |
| Q2 2124 | $11.4B | $1.82B | |
| Q3 2124 | $12.1B | $1.94B | Back-to-school PCS |
| Q4 2124 | $13.0B | $2.08B | Holiday season |
| **FY 2124** | **$47.3B** | **$7.52B** | |

## Contingency & Reserves

| Reserve | Amount | Purpose |
|---------|--------|---------|
| Economic Contingency | $420M | Recession buffer |
| R&D Contingency | $180M | Project overruns |
| M&A Reserve | $500M | Opportunistic acquisitions |
| Legal Reserve | $75M | Litigation defense |
| **Total Reserves** | **$1.175B** | |
